GlcNAc-6-O-sulfotransferase is involved in formation of 6-sulfo-N-acetyllactosamine-containing structures such as 6-sulfo sialyl Lewis x. We investigated the mode of expression of GlcNAc-6-O-sulfotransferase during postimplantation embryogenesis in the mouse by in situ hybridization. Sulfotransferase mRNA was not detected on embryonic day (E) 6.5, while on E7.5 it was detected in the mesoderm, ectoderm, and ectoplacental cone. On E10.5, the sulfotransferase signals were mainly observed in the nervous tissue. On E12.5 and 13.5, various tissues in the process of differentiation expressed this mRNA. Several epithelial and mesenchymal tissues undergoing epithelial-mesenchymal interactions strongly expressed the mRNA. For example, in the developing tooth strong sulfotransferase mRNA expression was found only in the condensing mesenchyme on E13.5. On E13.5 and 15.5, the sites showing intense expression of the sulfotransferase again became restricted. In the brain, sulfotransferase mRNA was frequently found as discrete signals in narrow regions. These results suggest that 6-sulfo-N-acetyllactosamine structures have important roles in development. On E13.5 and 15.5, G152 (6-sulfo sialyl Lewis x antigen) was expressed in the neocortex, and AG223 (6-sulfo Lewis x antigen) in the thalamus and neocortex where the sulfotransferase signal was detected. However, in other organs, expression of these antigens did not correlate with the sulfotransferase mRNA, implicating complex nature of regulation of expression of the fucosyl 6-sulfo antigens.
Introduction
Carbohydrate structures are altered according to spatially and temporally controlled developmental programs (Muramatsu, 1988) . Some of the developmentally regulated carbohydrate structures, especially those in non-reducing termini of glycans in glycoproteins or glycolipids, are believed to play important roles in regulation of differentiation and development.
6-Sulfated GlcNAc residues have recently attracted considerable interest since they are located not only in keratan sulfate (Kjellén and Lindhal, 1991) but also in mucin-type as well as asparagine-linked glycans (Spiro and Bhoyroo, 1988; de Waard et al., 1991; Shilatifard et al., 1993; Lo-Guidice et al., 1994) . Notably, 6-sulfo sialyl Lewis x and 6′-sulfo sialyl Lewis x structures are present in GlyCAM-1, an endothelial ligand of L-selectin, which plays a key role in the initial stage of lymphocyte homing to lymph nodes . Sulfation of the ligand is essential for recognition by L-selectin (Imai et al., 1993) . Both 6-sulfo sialyl Lewis x and 6′-sulfo sialyl Lewis x have been proposed to be important as the L-selectin ligand Tsuboi et al., 1996; Maly et al., 1996; Ohmoto et al., 1996; Galustian et al., 1997; Mitsuoka et al., 1997 Mitsuoka et al., , 1998 . However, immunological (Mitsuoka et al., 1997 (Mitsuoka et al., , 1998 , enzymological (Maly et al., 1996) and chemical studies (Ohmoto et al., 1996; Galustian et al., 1997) , which have been carried out recently, favor the view that the former is the preferred structure.
We recently cloned mouse GlcNAc-6-O-sulfotransferase (Uchimura et al., 1998b) . The enzyme transferred sulfate to GlcNAc exposed to the nonreducing end, but not to internally located GlcNAc. This specificity of the cloned enzyme agrees with that of the unpurified enzyme preparations recently studied (Spiro et al., 1996; Degroote et al., 1997) . The cloned GlcNAc-6-O-sulfotransferase has been concluded to participate in synthesis of 6-sulfo sialyl Lewis x structures, and was detected in high endothelial venules of mesenteric lymph nodes, suggesting that the enzyme is involved in formation of L-selectin ligands (Uchimura et al., 1998b) .
In the present study, we analyzed expression of GlcNAc-6-O-sulfotransferase during postimplantation embryogenesis in the mouse to obtain information regarding the developmental roles of the sulfotransferase and its products.
Results

Overall mode of expression of GlcNAc-6-O-sulfotransferase mRNA during mouse embryogenesis
On embryonic day 6.5 (E6.5), GlcNAc-6-O-sulfotransferase mRNA was not detected in the embryo proper nor in extraembryonic tissues ( Figure 1B ). On E7.5, the sulfotransferase was expressed in the mesoderm and ectoderm, and also in the ectoplacental cone ( Figure 1E ). On E10.5, the mRNA was found in the nervous system including spinal ganglia ( Figure 1H ). The tip of the jaw was also positive. On E13.5, in addition to the nervous system strong to moderate signals were found in several organs in which epithelial-mesenchymal interactions were taking place ( Figure 2B , Table I ), i.e., dental mesenchyme ( Figure 2G ), ductal precursor cells of the pancreas ( Figure 2H ), condensing mesenchyme of the lung ( Figure 2I ), mesenchyme around the salivary epithelium ( Figure 2K ), epithelium of whisker follicles and the kidney, the facial mesenchyme, and the digital mesenchyme (Table I ). On E15.5, strong expression of the mRNA again became restricted; dental mesenchyme showed only weak expression ( Figure 3F ), and the duct epithelium of the pancreas ( Figure 4H ), the brain ( Figure 5 ), and the spinal cord showed strong expression (data not shown). Northern blotting analysis revealed that the amount of GlcNAc-6-O-sulfotransferase mRNA was not significantly altered from E9.5 to E17.5 ( Figure 6 ). Among the 3 isoforms of the mRNA, the smallest was the predominant form throughout the embryonic period, as was the case in adult organs (Uchimura et al., 1998b) . arrowheads in (K) show expression in the mesenchyme around the salivary gland. Abbreviations: b, brain; de, dental epithelium; dm, dental mesenchyme; f, facial process; h, heart; k, kidney; l, lung; o, olfactory organ; p, pancreas; s, salivary gland; sb, segmental bronchi; t, tooth. Bars in (A), 500 µm; bars in (D-F) and (J), 100 µm. .5, weak expression was detected in the inner enamel epithelium (arrowhead). Abbreviations: de, dental epithelium; dm, dental mesenchyme; dp, dental papilla mesenchyme; ie, inner enamel epithelium; Mc, Meckel's cartilage. Bars, 100 µm.
The mode of developmentally regulated expression of the sulfotransferase mRNA is more fully explained in 3 sites, namely the tooth, pancreas, and brain, in the following sections. 
GlcNAc-6-O-sulfotransferase expression during tooth development.
The tooth is a good model in which to study the molecular mechanisms of inductive interactions of two tissues, the epithelial layer and the mesenchymal layer. On E12.5, there was no detectable expression of the sulfotransferase mRNA in the epithelium or mesenchyme ( Figure 3B ). On E13.5, strong expression was found in the condensed dental mesenchyme ( Figure 3D ). On E14.5, only weak expression was observed in the dental papilla mesenchyme ( Figure 3F ). On E15.5, weak expression was detectable in the inner enamel epithelium ( Figure  3H ). Therefore, strong expression of the sulfotransferase gene occurred only at a specific developmental stage at a restricted site.
GlcNAc-6-O-sulfotransferase expression during pancreatic development.
Ductal epithelium of the pancreas expressed the mRNA on E12.5 ( Figure 4B ), E13.5 ( Figure 3D ), E14.5 ( Figure 4F ), and E15.5 ( Figure 4H ) with similar intensity. Scarcely any signal was detected in the mesenchyme.
GlcNAc-6-O-sulfotransferase expression during brain development.
On E10.5, strong signals were observed in the telencephalon (neocortex, Nc) and the inferior tectal neuroepithelium (It), and moderate signals were seen in the anterior thalamus ( Figure 5A ). In It, the region with strong expression of the sulfotransferase was located in a narrow region stripe. On E12.5, distinct signals were found in the strionuclear neuroepithelium of basal ganglia (St, Figure 5D ), intermediate hypothalamic neuroepithelium (Hli, Figure 5E ), dorsal isthmal neuroepithelium (Is), and differentiating field of isthmus (Is*) beneath the ventral isthmal neuroepithelium ( Figure 5F ). The telencephalon, hippocampus, thalamus, and posterior pons were moderately positive ( Figure 5B ). On E15.5, the thalamus (T) and hypoglossal nucleus of the medulla (Med) were strongly positive, and the olfactory bulb (o), rhinencephalic subventricular zone, neocortex (c), and tectum (superior colliculus and inferior colliculus) showed moderate signals ( Figure 5G ). The sense probe gave a few signals in the brain both on E12.5 and E15.5. It is of special interest that the sulfotransferase mRNA was distinctly located in specific subfields during brain development.
Distribution of 6-sulfo Lewis x and 6-sulfo sialyl Lewis x antigens in E12.5-E15.5 embryos
N-Acetylglucosamine-6-O-sulfotransferase is expected to be involved in synthesis of a variety of glycan structures. Among them, we investigated the distribution of 6-sulfo Lewis x and 6-sulfo sialyl Lewis x antigens, since monoclonal antibodies specific to these structures are available.
The antigenically positive sites on E13.5 and E15.5 are summarized in Table II , and typical mode of expression in E13.5 brain is demonstrated in Figure 7 and E12.5 organs in Figure 8 . Generally speaking, the antigenic distribution on E13.5 is similar to that on E12.5 and E15.5. In the brain, AG223 (6-sulfo Lewis x) and G152 (6-sulfo sialyl Lewis x) antigens were similarly located, except that the thalamus expressed the former but not the latter antigen (Figure 7) . The thalamus and neocortex also expressed 5D4, 6-sulfo poly-N-acetyllactosamine antigenic epitope, on E13.5 (Figure 7) . In other organs, AG223 was strongly expressed in some regions, and moderate G152 expression was seen in the region, where AG223 was strongly expressed (Table II, Figure 8 ). In the brain, the antigenic expression and that of GlcNAc-6-O-sulfotransferase overlapped partially, namely, in the neocortex and thalamus. However, in other organs, the antigenic expression and that of the sulfotransferase did not overlap. This can be explained by considering that (1) expression of fucosyltransferase is the important factor regulating antigenic expression and/or that (2) GlcNAc-6-O-sulfotransferase with different structure is present in these embryonic organs and play important roles in the expression of these fucosylated 6-sulfo-Nacetyllactosamine antigens.
By immunostaining we also examined the possible expression of L-selectin, which is a candidate molecule to recognize 6-sulfo sialyl Lewis x, but it was not detected in tissue sections of E13.5 and E15.5 embryos. The immunostaining procedure was valid, since intense staining of lymphocytes was observed when sections of the spleen from adult mice fixed under identical conditions were reacted with anti-L-selectin antibody.
Discussion
The expression of GlcNAc-6-O-sulfotransferase was found to be strictly regulated both spatially and temporally during mouse embryogenesis. This restricted mode of expression implies that the enzyme may not be a sulfotransferase involved in synthesis of keratan sulfate in a wide variety of tissues. Indeed, the chromosomal location of human GlcNAc-6-O-sulfotransferase is different from that of the causative gene of macular corneal dystrophy (Uchimura et al., 1998c) , which is probably due to hindrance of GlcNAc-6-O-sulfation of corneal keratan sulfate (Vance et al., 1996) . However, the possibility that the GlcNAc-6-O-sulfotransferase studied here participates in keratan sulfate biosynthesis in specific tissues can not be excluded.
The developmentally regulated expression of GlcNAc-6-Osulfotransferase is of special interest for the following reasons. First, the sulfotransferase is frequently expressed in one of two tissues undergoing epithelial-mesenchymal interactions, which is one of the fundamental processes in organogenesis, e.g., in the condensing mesenchyme of the tooth at E13.5. Among the interacting tissues, mesenchymal expression was also observed in the lungs and the salivary glands. However, in the pancreas, whisker follicles and kidney, epithelial tissues strongly expressed the message. Second, restricted regions of the brain showed distinct expression of the mRNA between E12.5 and 15.5. In particular, segmental sulfotransferase expression was observed in the inferior tectal neuroepithelium on E10.5 and the strionuclear neuroepithelium, intermediate hypothalamic neuroepithelium, and dorsal isthmal neuroepithelium on E12.5.
The results described in this paper clearly indicated the importance of 6-sulfo-N-acetyllactosamine-containing epitopes in mouse development. These findings raised three major questions to be answered by subsequent studies. First, the proteins which recognize the 6-sulfo-N-acetyllactosamine-containing epitopes in specific regions of mouse embryos should be identified, since L-selectin, which recognizes sulfated sialy Lewis x structures (Imai et al., 1993) , has not been detected in embryonic tissues. Second, it is necessary to determine the structure of the sulfated epitopes formed by the sulfotransferase localized in developmentally significant regions; 6-sulfo sialyl Fig. 6 . Northern blotting analysis of GlcNAc6ST gene expression in developing mouse embryos. Aliquots of ten µg of total RNA from E 9.5, E11.5, E13.5, E15.5, and E17.5 mouse embryos were hybridized with a 32 P-labeled mouse GlcNAc6ST cDNA probe. As a control, the same blot was rehybridized with a mouse GAPDH cDNA probe (bottom). Lewis x, 6-sulfo Lewis x and/or 6-sulfo-N-acetyllactosamine are possible candidates. In E15.5 and E13.5 embryonic brain, the thalamus expressed AG223(6-sulfo Lewis x) antigen, and the neocortex AG223 and G152(6-sulfo sialyl Lewis x) antigen. Miller et al. (1997) reported the presence of 6-sulfo poly N-acetyllactosamine antigenic epitope, 5D4, in these regions of E14-E16 rat embryos, and we confirmed its expression in the regions of E13.5 mouse embryos. The thalamus strongly expressed GlcNAc-6-O-sulfotransferase and the neocortex did it moderately. Therefore, in the brain, the region-specific expression of the sulfotransferase mRNA correlated, at least partly, with the distribution of arrays of 6-sulfo-N-acetyllactosamine containing structures. However, in other organs, the mode of the antigenic distribution did not correlate with the mRNA. Our own studies using 5D4 antibody revealed specific antigenic localization only in the brain and the heart (unpublished observations). In other words, at the present time, in situ hybridization to detect the mRNA is the only one method capable of implying stage-specific expression of 6-sulfo-N-acetyllactosamine-containing structures in embryonic organs other than the brain. Lastly, and most importantly, the developmental roles of 6-sulfo-N-acetyllactosamine-containing structures in embryogenesis should be investigated. To address this question, gene manipulation studies of the sulfotransferase are currently in progress in our laboratory. 
Materials and methods
In situ hybridization
Embryos were collected from the inbred mouse strain C57BL6J. The morning when vaginal plugs were detected was designated as day 0.5 of gestation. Mice were anesthetized with Nembutal and perfused with 10 ml of saline followed by 50 ml of 4% paraformaldehyde in Dulbecco's phosphate-buffered saline (PBS). Both the embryos and those in their decidua were fixed in 4% paraformaldehyde in PBS at 4_C overnight. After embedding in paraffin, sections 5 µm thick were cut and placed on silane-coated slide glasses. They were then subjected to in situ hybridization or to hematoxylin-eosin staining to localize the site of signals. For generation of in situ hybridization probes, a 0.6 kb PstI fragment of the cDNA encoding mouse GlcNAc-6-O-sulfotransferase (Uchimura et al., 1998b (Uchimura et al., , nucleotide number 962-1561 ; GenBank accession number AB011451) was inserted into pBluescript II SK-(Stratagene, CA). After linearizing the template plasmid by digestion with appropriate restriction enzymes, T3 or T7 RNA polymerase was used to perform in vitro transcription. Digoxigenin-11-dUTP-labeled single-stranded RNA was prepared using a DIG RNA labeling Kit (Boehringer Mannheim, Germany). After ethanol precipitation, the products were dissolved in 50 µl of H 2 O, 20 U of RNase inhibitor, and 50 µl of deionized formamide, and then stored at -80_C until use. in situ hybridization was performed as described previously (Fan et al., 1998) .
Immunohistochemistry
Monoclonal antibodies AG223 and G152 (mouse IgM) were produced as described previously (Mitsuoka et al., 1998) , while 5D4 (rat IgG) was purchased from Seikagaku Kogyo, Japan.
MEL-14, a monoclonal antibody to mouse L-selectin (mouse IgG), was purchased from Parmingen, CA.
Fluorescein isothiocyanate (FITC)-labeled IgG fraction of rabbit anti-mouse IgM, rabbit anti-mouse IgG, and of goat anti-rat IgG were purchased from Cappel Laboratories (Cochranville, PA).
For indirect immunofluorescence microscopy, two µm thick frozen sections of mouse embryos were cut with a cryocut and were fixed in cold acetone for 10 min. Indirect immunofluorescence staining was performed according to the method previously described (Akahori et al., 1997) . The sections were immersed in 0.01 M phosphate-buffered saline (PBS) containing 1% normal rabbit or normal goat serum for 20 min to avoid nonspecific binding of the secondary antibodies. After washing with PBS, the sections were incubated with an optimal concentration of the first antibodies followed by the incubation with FITC labeled secondary antibodies. All the sections were mounted with 90% glycerol in PBS containing p-phenylenediamine (Platt et al., 1983) , and were observed with Olympus BH2 epifluorescence microscopy.
Northern blotting analysis
RNA was extracted from C57BL/6J mouse embryos as described previously (Chomczynski and Sacchi, 1987) , and electrophoresed on a 1.0% agarose gel containing 5% formaldehyde (v/v). Hybridization was performed as described (Uchimura et al., 1998a ) using a 368 bp fragment of mouse GlcNAc-6-O-sulfotransferase cDNA (Uchimura et al., 1998b , nucleotide number 1139-1506) as a probe.
